A Nomogram Based on Platelet Distribution Width-to-Lymphocyte Ratio to Predict Overall Survival in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma
Runzhi Wang,Rong Zhao,Zhongguo Liang,Kaihua Chen,Xiaodong Zhu
DOI: https://doi.org/10.2147/jir.s462833
IF: 4.5
2024-07-04
Journal of Inflammation Research
Abstract:Runzhi Wang, 1 Rong Zhao, 2 Zhongguo Liang, 1 Kaihua Chen, 1 Xiaodong Zhu 1, 3– 6 1 Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, 530021, People's Republic of China; 2 Department of Radiation, Inner Mongolia Autonomous Region People's Hospital, Hohhot, Inner Mongolia autonomous Region, 010020, People's Republic of China; 3 Department of Oncology, Wuming Hospital of Guangxi Medical University, Nanning, Guangxi, 530199, People's Republic of China; 4 Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, Guangxi, 530021, People's Republic of China; 5 Guangxi Clinical Medicine Research Center of Nasopharyngeal Carcinoma, Nanning, Guangxi, 530021, People's Republic of China; 6 Guangxi Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Nanning, Guangxi, 530021, People's Republic of China Correspondence: Xiaodong Zhu, Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, 71 He-Di Road, Nanning, 530021, People's Republic of China, Tel +86 15778028340, Email Purpose: To evaluate the prognostic significance of platelet distribution width-to-lymphocyte ratio (PDWLR) in patients with locoregionally advanced nasopharyngeal carcinoma (LA-NPC). Moreover, a nomogram based on PDWLR was built and validated to predict the overall survival (OS) of this population. Patients and Methods: All LA-NPC patients who were diagnosed and treated between January 2015 and December 2017 at Guangxi Medical University Cancer Hospital were included. Cox regression analyses were performed to assess PDWLR and clinical features that might affect OS to screen for independent predictors. The independent predictors and important clinical variables were used to build and validate a nomogram for predicting OS. Then, the capability of the model was estimated by discrimination, calibration and clinical usefulness. Risk stratification was conducted using the nomogram-calculated risk score, and the comparison of survival in the high-risk group and the low-risk group was through Kaplan–Meier method. Results: This study included 746 LA-NPC patients. Multivariate Cox analysis suggested that age (hazard ratio [HR]: 1.81, 95% confidence interval [CI]: 1.18– 2.78, P = 0.007), gender (HR: 2.03, 95% CI: 1.12– 3.68, P = 0.019), pre-treatment plasma Epstein–Barr virus (EBV) DNA (HR: 1.55, 95% CI: 1.01– 2.39, P = 0.047), PDWLR (HR: 2.61, 95% CI: 1.67– 4.09, P < 0.001) were independent predictors of OS. Compared to the 8th edition TNM staging system, the nomogram based on the above four factors and important clinical variables (T stage and N stage) demonstrated better predictive performance. Moreover, the model had the ability to identify individuals at high risk. Conclusion: PDWLR was a promising negative predictor for patients with LA-NPC. The nomogram based on PDWLR demonstrated better predictive performance than the current staging system. Keywords: nomogram, platelet distribution width-to-lymphocyte ratio, inflammatory biomarker, locoregionally advanced nasopharyngeal carcinoma, overall survival Nasopharyngeal carcinoma (NPC) originates from nasopharyngeal mucosal epithelium, and its geographical distribution is extremely uneven. 1 According to Global Cancer Statistics and Cancer statistics in China, it was estimated that there were 120,416 new cases of NPC worldwide and 64,165 new cases in China, representing half of all new cases worldwide in 2022. 2,3 The non-keratinizing subtype is the most primary pathology subtype in endemic areas and has a strong correlation with infection of Epstein–Barr virus (EBV). 4 Owing to the insidious, non-specific early symptoms and the complex anatomy of the nasopharynx, there are over 70% of the patients diagnosed in locally advanced stage. 1 Currently, concurrent chemoradiotherapy (CCRT) is the core regimen for locally advanced nasopharyngeal carcinoma (LA-NPC), but there are still some patients who fail treatment due to loco-regional recurrence and distant metastasis. 5,6 For such patients, the choice of CCRT alone, induction chemotherapy (IC) after CCRT or CCRT after adjuvant chemotherapy (AC) is still controversial. 7–12 Thus, identifying patients who may benefit from additional chemotherapy is important and challenging. Presently, the 8th edition tumor-node-metastasis (TNM) staging system is the primary basis for treatment options and prognostic prediction for patients with NPC. 13,14 Although LA-NPC patients are in the same TNM stage, they may possess -Abstract Truncated-
immunology